1171 CLN-418, a clinical-stage B7H4 x 4–1BB bispecific antibody with potential to treat patients with a wide range of solid tumors

• Yun He,
• Ella Ioffe,
• Bing Huang,
• Naveen K Mehta,
• Patrick A Baeuerle,
• Jennifer S Michaelson,
• Kristan A Meetze,
• Irina M Shapiro,
• Hanna Dobrowolska

Affiliations

Yun He

2 School of Medicine, Imperial College School of Medicine, London, UK

Ella Ioffe

Aff28 grid.418961.30000000404722713Regeneron Tarrytown NY USA

Bing Huang

Department of Public Health and Preventive Medicine, Jinan University School of Medicine, Guangzhou, Guangdong, China

Naveen K Mehta

Cullinan Oncology Inc, Cambridge, Massachusetts, USA

Patrick A Baeuerle

Cullinan Oncology Inc, Cambridge, Massachusetts, USA

Jennifer S Michaelson

Cullinan Oncology Inc, Cambridge, Massachusetts, USA

Kristan A Meetze

1Cullinan Oncology, Inc., Cambridge, MA, USA

Irina M Shapiro

1Cullinan Oncology, Inc., Cambridge, MA, USA

Hanna Dobrowolska

2Cullinan Oncology, Inc., Cambridge, MA, USA